Valgen Medtech

Valgen Medtech is dedicated to the interventional treatment of structural heart diseases.Continuously providing better solutions for patients around the world.

[Valgen Medtech @valgenmed]

@EuroInterventio @valgenmed

[EuroIntervention @EuroInterventio]

The DRAGONFLY-DMR study showed the DragonFly valve repair system is safe and effective for treating severe chronic mitral regurgitation (DMR) in high-risk patients. Its unique design could offer new options in transcatheter edge-to-edge repair (#TEER) techniques, particularly for patients with complex heart valve structures. https://t.co/SfReFtJpgu

[Interv. Cardiol. H. Ramón y Cajal @Card_IntervRyC]

The first two MR cases with the DragonFly device! Great teamwork in the cath lab! @ASanchezRecalde @luisa_car @AnaPardo213 @RyCImagenCardio

[Valgen Medtech @valgenmed]

#dragonfly The DragonFly™ Transcatheter Mitral Valve Repair System, as the first transfemoral vein edge-to-edge repair product developed in-house in China, passed its review in accordance with the Special Review Procedure for Innovative Medical Devices in March 2021